Citius Pharmaceuticals, Inc. (CTXR) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$20.8K2012: -$917.8K2013: -$1.10M2014: -$183.2K2015: -$2.39M2016: -$5.90M2017: -$7.97M2018: -$11.32M2019: -$12.44M2020: -$16.93M2021: -$24.25M2022: -$28.36M2023: -$29.06M2024: -$28.20M2025: -$26.55M-$26.55M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$26.55M+5.8%
2024-$28.20M+3.0%
2023-$29.06M-2.5%
2022-$28.36M-17.0%
2021-$24.25M-43.2%
2020-$16.93M-36.1%
2019-$12.44M-9.9%
2018-$11.32M-42.0%
2017-$7.97M-35.1%
2016-$5.90M-147.4%
2015-$2.39M-1202.3%
2014-$183.2K+83.3%
2013-$1.10M-19.3%
2012-$917.8K-4316.5%
2011-$20.8K